Related Experiment Video
Updated: Apr 19, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Similarities and differences between pediatric and adult patients with systemic lupus erythematosus
T Tarr1, B Dérfalvi2, N Győri1
1Department of Clinical Immunology, University of Debrecen, Hungary.
Insights
Pediatric-onset systemic lupus erythematosus (SLE) presents with more kidney, blood, skin, and mouth issues than adult-onset SLE. Adult-onset SLE more frequently involves neurological symptoms and joint pain, differing in antibody profiles and treatments.
Area of Science:
- Rheumatology
- Pediatric Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune condition.
- While prevalent in women of childbearing age, SLE can also affect children (pediatric-onset SLE).
- Understanding differences between adult and pediatric SLE is crucial for effective management.
Purpose of the Study:
- To compare the clinical course of adult-onset SLE versus pediatric-onset SLE.
- To identify distinct organ manifestations, laboratory findings, and immunoserological characteristics.
- To inform optimal treatment strategies and prognosis for different age groups.
Main Methods:
- Retrospective analysis of medical records from 342 adult patients and 79 pediatric patients.
- Review of organ manifestations, laboratory parameters, and immunoserological data.
- Statistical evaluation using SPSS software.
Main Results:
- Pediatric SLE showed higher rates of lupus nephritis, hematological disorders, photosensitivity, butterfly rash, and mucosal ulceration.
- Adult SLE exhibited more frequent neurological symptoms and polyarthritis.
- Adult-onset SLE had higher levels of anti-SSA, anti-SSB, and antiphospholipid antibodies; children received more IV immunoglobulin and mycophenolate mofetil.
Conclusions:
- Pediatric and adult-onset SLE exhibit significant differences in clinical presentation, serology, and treatment.
- Recognizing these distinctions is vital for tailoring patient care and improving outcomes.
- Further research into age-specific SLE pathogenesis and management is warranted.
Abstract:
Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease with highest prevalence among women of childbearing age. However, children younger than 16 years also can develop SLE (childhood-onset lupus/juvenile-type SLE). The aim of our study was to compare the clinical course of adult and pediatric-onset SLE. Data from 342 adult patients followed at the University of Debrecen, Hungary, and 79 children documented in the Hungarian National Pediatric SLE registry were analyzed using hospital medical records. Organ manifestations, laboratory parameters, and immunoserological characteristics were reviewed and the results were evaluated using SPSS for Windows software.Gender distribution was not significantly different between groups with disease starting in childhood vs adulthood. The prevalence of the following manifestations was significantly higher for pediatric than for adult-onset disease including: lupus nephritis (43% pediatric vs 26.4% for adult-onset), hematological disorders (57% vs 36.4%), photosensitivity (20% vs 9%), butterfly rash (61% vs 35.5%) and mucosal ulceration (11.4% vs 4%). For adult-onset SLE, neurological symptoms (30% vs 6%) and polyarthritis (86% vs 68%) occurred significantly more frequently than in children. Anti-SSA, anti-SSB and antiphospholipid antibodies were detected at significantly higher levels in adult-onset patients compared to those in pediatrics. Children were more commonly given high-dose intravenous immunoglobulin treatment (6.3% vs 0.6%) and mycophenolate mofetil (15.2% vs 5.3%) than adults.These results suggest that pediatric and adult-onset SLE differ in multiple aspects, and it is important to recognize these differences for optimal treatment and prognosis of these patients.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

